Stakeholder Engagement and Feedback -Management of Acute and Chronic Pain

Stakeholder Engagement and Feedback –

Management of Acute and Chronic Pain

Individual Conversation Protocols

OMB Control No. 0920-1050

Exp. Date 05/31/2022

Public reporting burden of this collection of information is estimated to average 90 minutes per respondent. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia, 30333; ATTN: PRA (0920-1050).

Structure

CDC will be hosting two types of engagements

1. Stakeholder Sessions- These will be in-person convenings of groups of no more than 20 individuals in which the project team will listen and ask participants to share and discuss their personal and individual perspectives and experiences related to the themes described below. Although each session will address all three themes, there will not be a uniform set of questions asked in each session.

2. Individual Conversations- These will be dialogues during which the project team will meet in person with individual participants to listen and ask each personal perspective and experience related to the themes described below. Although each individual conversation will address all three themes, there will not be a uniform set of questions asked in each conversation.

Themes to Be Explored

CDC invites input specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments (e.g., exercise therapy or cognitive behavioral therapy). These topics are:

• Experiences managing pain, which might include benefits, risks, and/or harms of the pain management options listed above.

• Experiences choosing among the pain management options listed above, including considering factors such as each option’s accessibility, cost, benefits, and/or risks.

• Experiences getting information needed to make pain management decisions.

Protocols

• Stakeholder Session

• Individual Conversation

INDIVIDUAL CONVERSATION PROTOCOL

PARTICIPANTS

1-on-1 Conversations (per location)

Up to 30 patients, family members, caregivers, providers, not present in sessions

AGENDA (90 min.)

Introductions & Overview (15 min.)

• Facilitators welcome participant

• Explain goals & process of conversation

• Emphasize spirit of session

• Reiterate consent

One-on-One Discussion (65 min.)

• Will follow natural conversation patterns which may take different paths depending on what the participant shares and engages about.

• Example starter questions –

  • Tell us about a critical situation or moment in your experience with pain (or your patients who have pain, in a healthcare provider.

  • What is the greatest benefit of using opioids to manage pain, from your perspective?

  • What is the greatest risk or harm of using opioids to manage pain, from your perspective?

  • What is your thought process when you’re balancing between those risks and benefits?

  • What are your views on non-opioid options to manage pain?

  • What do you think other people in your shoes need to know that they may not know already?

  • If you were seeking out additional information about pain or pain management, who or where would you look to?

  • Have you heard of CDC’s Opioid Prescribing Guideline and, if so, how has it affected you?

  • What is one thing that could have made your experience managing pain better?

Expectations & Conclusion (10 min.)

• Facilitators thank participant

• Preview next steps

2